
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
SSE:688621.SS
54.23 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Beijing Sun-Novo Pharmaceutical Research Co., Ltd. |
Symbool | 688621.SS |
Munteenheid | CNY |
Prijs | 54.23 |
Beurswaarde | 6,073,760,000 |
Dividendpercentage | 0% |
52-weken bereik | 28.9 - 59.98 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yujing Liu |
Website | https://www.sun-novo.com |
An error occurred while fetching data.
Over Beijing Sun-Novo Pharmaceutical Research Co., Ltd.
Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)